KRAS and familial pancreatic carcinoma: In KRAS G12D mouse model of pancreatic cancer surviving cells responsible for tumor relapse rely on oxidative phosphorylation, making the combined inhibition of the KRAS pathway and mitochondrial respiration a possible therapeutic strategy (84).